1418 Objectives Although [18F] FDG PET is established as one of the first choice imaging
modalities in the diagnosis of malignancies, there are several problems to solve in clinical …

Abstract Objective α-N-methyl-11 C-methylaminoisobutyric acid (11 C-MeAIB) is a selective
substrate of system A amino acid transport, and known to accumulate in malignant lesions …

Objective (18) F-FDG-PET is used worldwide for oncology patients. However, we sometimes
encounter false positive cases of (18) F-FDG PET, such as moderate uptake in the …

1097 Objectives anti-1-amino-3-[18 F] fluorocyclobutane-1-carboxylic acid (anti-3-[18 F]
FACBC) is a synthetic amino acid positron emission tomography (PET) radiotracer which is …

1727 Objectives To clarify the difference between system A and L amino acid transport
imaging in clinical PET, we analyze the pharmacokinetics and the parametric images of [N …

1992 Objectives We have presented system A amino acid PET imaging with [N-methyl-C-11]
α-methylaminoisobutyric acid (MeAIB) in patients with glioblastoma multiforme (GBM) as a …

Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti–18F-FACBC) is an amino acid
PET tracer that has shown promise for visualizing prostate cancer. Therefore, we aimed to …

e15138 Background: Existing imaging techniques have limitations for the detection and
staging of prostate cancer. 1-amino-3-[18F] fluorocyclobutane-1-carboxylic acid ([18F] GE …

Introduction To clarify the difference between system A and L amino acid transport imaging
in PET clinical imaging, we focused on the use of α-[N-methyl-11 C]-methylaminoisobutyric …

Purpose The purpose of this study was to evaluate the usefulness of L-4-borono-2-18 F-
fluoro-phenylalanine (18 F-FBPA) as a tumor-specific probe, in comparison to 18 F-FDG and …